Fingerprint
Dive into the research topics of 'A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Vaishali Sanchorawala, Giovanni Palladini, Vishal Kukreti, Jeffrey A. Zonder, Adam D. Cohen, David C. Seldin, Angela Dispenzieri, Arnaud Jaccard, Stefan O. Schönland, Deborah Berg, Huyuan Yang, Neeraj Gupta, Ai Min Hui, Raymond L. Comenzo, Giampaolo Merlini
Research output: Contribution to journal › Article › peer-review